HABIB NAGY / CURRICULUM VITAE | |||
HABIB Nagy | |||
|
|||
POSITION / TITLE | |||
Professor of Hepatobiliary Surgery Faculty of Medicine
Imperial College London (UK). Chief of HPB Surgery, Hammersmith Hospital (UK) Honoarary Consultant Surgeon Hammersmith Hospitals NHS Trust. |
|||
SPECIALITY | |||
Liver, Biliary and Pancreatic Surgery. | |||
HOSPITAL CAREER | |||
Hammersmith Hospitals NHS Trust - London (UK). | |||
UNIVERSITY CAREER | |||
Imperial College London. | |||
CLINICAL ACTIVITIES | |||
Surgical solutions to HPB Cancers and Diseases. Gene Therapy of Liver Cancer. Immunotherapy of Liver Cancer. |
|||
MAIN PUBLICATIONS | |||
Hong SS, Habib NA, Franqueville L, Jensen S, Boulanger
PA. Identification of adenovirus (Ad) penton base neutralizing epitopes
by use of sera from patients who had received conditionally replicative
Ad (Addl1520) for treatment of liver tumors. Journal of Virology 2003;77:10366-10375 Weber JC, Navarra G, Habib NA, Bachellier P, Jaeck D. Laparoscopic radiofrequency-assisted liver resection. Surgical Endoscopy 2003 Habib NA, Spalding D, Navarra G, Nicholls JP. How we do a bloodless partial splenectomy. American Journal of Surgery 2003;186:164-166 Serracino-Inglott F, Habib NA. Adenosine pre-conditioning attenuates hepatic reperfusion injury in the rat by preventing the down-regulation of endothelial nitric oxide synthase. BMC Gastroenterology 2002;2:22 F Serracino-Inglott, Habib NA. Differential nitric oxide synthase suppression during hepatic ischaemia-reperfusion. American Journal of Surgery 2003:185:589-595 Habib NA, Mitry RR, Sarraf CE, Jiao LR, Havlik R, Nicholls J, Jensen SL. Assessment of growth inhibition and morphological changes in in vitro and in vivo hepatocellular carcinoma models post treatment with dl1520 adenovirus. Cancer Gene Therapy 2002;9:414-420. Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischaemia-reperfusion injury. American Journal of Surgery 2001;181:160-166. Habib NA, Salama H, Abu Median A, Anis I, Al Aziz R, Sarraf CE, Mitry RR, Havlik R, Seth P, Hartwigsen J, Bhushan R, Nicholls JP, Jensen S. Clinical trial of E1B-deleted (dl1520) gene therapy for hepatocellular carcinoma. Cancer Gene Therapy 2002;9:254-259. Weber J-C, Navarra G, Jiao LR, Nicholls J, Jensen S, Habib NA. New technique for liver resection using heat coagulative necrosis. Annals of Surgery 2002;236:560-563. Havlik R, Kerkhoffs W, Jiao LR, Schumacher O, Reul H, Habib NA. Intravascular micropump for augmented liver perfusion: first in vivo experience. Artificial Organs 2001;25:392-394. Habib NA, Sarraf CE, Mitry RR, Havlik R, Nicholls J, Kelly M, Vernon CC, Gueret-Wardle D, El-Masry R, Salama H, Ahmed R, Michail N, Edward E, Jensen SL. E1B deleted adenovirus (dl1520) gene therapy for patients with primary and secondary liver tumours. Human Gene Therapy 2001;12:219-226. Jiao LR, Sefalian A, Mathie RT, Habib N, Davidson BR. Portal flow augmentation for liver cirrhosis. British Journal of Surgery 2000;87:984-991. Jiao LR, Seifalian AM, Davidson BR, Habib N. In vivo evaluation of an implantable portal pump system for liver perfusion. British Journal of Surgery 2000;87:1024-1029. Mitry RR, Sarraf CE, Havlik R, Habib NA Detection of adenovirus and initiation of apoptosis in hepatocellular carcinoma cells following AD-p53 treatment. Hepatology 2000;31:885-889. Jiao LR, El-Despky AA Seifalian AM, Habib NA, Davidson BR. Effect of liver blood flow and function on hepatic indocyanine green clearance measured directly in a cirrhotic animal model. British Journal of Surgery 2000;87:568-574. Jiao LR, Seifalian A, Habib NA, Davidson B. The effect of mechanically enhancing portal venous inflow on hepatic oxygenation, microcirculation and function in a rabbit model with extensive hepatic fibrosis. Hepatolog,y 1999;30:46-52. Jiao LR, Hansen PD, Havlik R, Habib N. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumours. American Journal of Surgery, 1999;117: 303-306. |
|||